Multidrug resistance protein I protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage

Journal of Experimental Medicine

Volumn 188, Issue 5, 1998, Pages 797-808

  Wijnholds, Jan ^a   Scheffer, George L ^c   Van Der Valk, Martin ^a   Van Der Valk, Paul ^c   Beijnen, Jos H ^b   Scheper, Rik J ^c   Borst, Piet ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blood testis barrier; Etoposide; Mucositis; Multidrug resistance protein 1; Polyuria

Indexed keywords

ETOPOFOS; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; DIABETES INSIPIDUS; GENE ISOLATION; INFERTILITY; MOUSE; MUCOSA INFLAMMATION; MULTIDRUG RESISTANCE; NEPHROTOXICITY; NONHUMAN; OROPHARYNX; POLYURIA; PRIORITY JOURNAL; SEMINIFEROUS TUBULE; TOXICITY TESTING;

ANIMALS; ANTINEOPLASTIC AGENTS; ETOPOSIDE; KIDNEY; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MOUTH MUCOSA; ORGANOPHOSPHORUS COMPOUNDS; OROPHARYNX; P-GLYCOPROTEIN; SEMINIFEROUS TUBULES; STOMATITIS; TESTIS; TONGUE;

EID: 0032494133     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.5.797     Document Type: Article

References (34)

1. Gottesman, M.M., C.A. Hrycyna, P.V. Schoenlein, U.A. Germann, and I. Pastan. 1995. Genetic analysis of the multidrug transporter. Annu. Rev. Genet. 29:607-649.
2. Zaman, G.J.R., and P. Borst. 1996. MRP, mode of action and role in MDR. In Multidrug Resistance in Cancer Cells. S. Gupta and T. Tsuruo, editors. John Wiley & Sons Ltd., Chichester, UK. 95-107.
3. Loe, D.W., R.G. Deeley, and S.P.C. Cole. 1996. Biology of the multidrug resistance-associated protein, MRP. Eur. J. Cancer. 32A:945-957.
4. Cole, S.P.C., G. Bhardwaj, J.H. Gerlach, J.E. Mackie, C.E. Grant, K.C. Almquist, A.J. Stewart, E.U. Kurz, A.M.V. Duncan, and R.G. Deeley. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1650-1654.
5. Zaman, G.J.R., M.J. Flens, M.R. van Leusden, M. de Haas, H.S. Mülder, J. Lankelma, H.M. Pinedo, R.J. Scheper, F. Baas, H.J. Broxterman, and P. Borst. 1994. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA. 91: 8822-8826.
6. Cole, S.P.C., K.E. Sparks, K. Fraser, D.W. Loe, C.E. Grant, G.M. Wilson, and R.G. Deeley. 1994. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54:5902-5910.
7. 4 and structurally related conjugates. J. Biol. Chem. 269:27807-27810.
8. Jedlitschky, G., I. Leier, U. Buchholz, K. Barnouin, G. Kurz, and D. Keppler. 1996. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 56:988-994.
9. Ishikawa, T., Z.-S. Li, Y.-P. Lu, and P.A. Rea. 1997. The GS-X pump in plant, yeast, and animal cells: structure, function, and gene expression. Biosci. Rep. 17:189-207.
10. Müller, M., C. Meijer, G.J.R. Zaman, P. Borst, R.J. Scheper, N.H. Mulder, E. de Vries, and P.L.M. Jansen. 1994. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA. 91:13033-13037.
11. Pulaski, L., G. Jedlitschky, I. Leier, U. Buchholz, and D. Keppler. 1996. Identification of the multidrug-resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes. Eur. J. Biochem. 241:644-648.
12. Zaman, G.J.R., N.H.P. Cnubben, P.J. Bladeren, R. Evers, and P. Borst. 1996. Transport of the glutathione conjugate of ethacrynic acid by the human multidrug resistance protein MRP. FEBS Lett. 391:126-130.
13. Zaman, G.J.R., J. Lankelma, O. van Tellingen, J. Beijnen, H. Dekker, C. Paulusma, F. Baas, and P. Borst. 1995. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc. Natl. Acad. Sci. USA. 92:7690-7694.
14. Kool, M., M. de Haas, G.L. Scheffer, R.J. Scheper, M.J.T. van Eijk, J.A. Juijn, F. Baas, and P. Borst. 1997. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57: 3537-3547.
15. Paulusma, C.C., P.J. Bosma, G.J.R. Zaman, C.T.M. Bakker, M. Otter, G.L. Scheffer, R.J. Scheper, P. Borst, and R.P.J. Oude Elferink. 1996. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science. 271:1126-1128.
16. Evers, R., M. Kool, L. van Deemter, H. Jansen, J. Calafat, L.C.J.M. Oomen, C.C. Paulusma, R.P.J. Oude Elferink, F. Baas, A.H. Schinkel, and P. Borst. 1998. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Invest. 101:1310-1319.
17. Schinkel, A.H., U. Mayer, E. Wagenaar, C.A.A.M. Mol, L. van Deemter, J.J.M. Smit, M. van der Valk, A.C. Voordouw, H. Spits, O. van Tellingen, et al. 1997. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA. 94: 4028-4033.
18. Schinkel, A.H., J.J. Smit, O. van Tellingen, J.H. Beijnen, E. Wagenaar, L. van Deemter, C.A.A.M. Mol, M.A. van der Valk, E.G. Robanus-Maandag, H.P.J. te Riele, et al. 1994. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 77:491-502.
19. Wijnholds, J., R. Evers, M.R. van Leusden, C.A.A.M. Mol, G.J.R. Zaman, U. Mayer, J.H. Beijnen, M. van der Valk, P. Krimpenfort, and P. Borst. 1997. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat. Med. 3:1275-1279.
20. Lorico, A., G. Rappa, R.A. Finch, D. Yang, R.A. Flavell, and A.C. Sartorelli. 1997. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res. 57:5238-5242.
21. Sparreboom, A., J. van Asperen, U. Mayer, A.H. Schinkel, J.W. Smit, D.K.F. Meijer, P. Borst, W.J. Nooijen, J.H. Beijnen, and O. van Tellingen. 1997. Limited oral bioavailability and active epithelial excretion of paclitaxel (taxol) caused by P-glycoprotein in the intestine. Proc. Natl. Acad. Sci. USA. 94:2031-2035.
22. Flens, M.J., G.J.R. Zaman, P. van der Valk, M.A. Izquierdo, A.B. Schroeijers, G.L. Scheffer, P. van der Groep, M. de Haas, C.J.L.M. Meijer, and R.J. Scheper. 1996. Distribution of the multidrug resistance-associated protein (MRP) in normal and malignant human tissues. Am. J. Pathol. 148:1237-1247.
23. Stride, B.D., G. Valdimarsson, J.H. Gerlach, G.M. Wilson, S.P.C. Cole, and R.G. Deeley. 1996. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. Mol. Pharmacol. 49:962-971.
24. Russell, L.D., and R.N. Peterson. 1985. Sertoli cell junctions: morphological and functional correlates. Int. Rev. Cytol. 94:177-211.
25. Cordon-Cardo, C., J.P. O'Brien, J. Boccia, D. Casals, J.R. Bertino, and M.R. Melamed. 1990. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem. 38:1277-1287.
26. Thiebaut, F., T. Tsuruo, H. Hamada, M.M. Gottesman, I. Pastan, and M.C. Willingham. 1987. Cellular localization of the multidrug resistance gene product in normal human tissues. Proc. Natl. Acad. Sci. USA. 84:7735-7738.
27. Tindall, D.J., D.R. Rowley, L. Murthy, L.I. Lipshultz, and C.H. Chang. 1985. Structure and biochemistry of the Sertoli cell. Int. Rev. Cytol. 94:127-149.
28. Brenner, B.M. 1996. The Kidney. 5th ed. B.M. Brenner and F.C. Rector, editors. W.B. Saunders Co., Philadelphia. 2653 pp.
29. Marks, J.E. 1997. Mucosal protectants and their application for head and neck chemoirradiation. Curr. Opin. Oncol. 9: 267-273.
30. Postmus, P.E., N.H. Mulder, D.T. Sleijfer, A.F. Meinesz, R. Vriesendorp, and E.G.E. de Vries. 1984. High-dose etoposide for refractory malignancies: a phase 1 study. Cancer Treat. Rep. 68:1471-1474.
31. Steinberger, A., and G. Klinefelter. 1993. Sensitivity of Sertoli and Leydig cells to xenobiotics in in vitro models. Reprod. Toxicol. 7:23-37.
32. Lipshultz, L.I., and S.S. Howards. 1991. Infertility in the Male. 3rd ed. Mosby, St. Louis. 576 pp.
33. Evers, R., G.J.R. Zaman, L. van Deemter, H. Jausen, J. Calafat, L.C.J.M. Oomen, R.P.J. Oude Elferink, P. Borst, and A.S. Schinkel. 1996. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J. Clin. Invest. 97:1211-1218.
34. Mayer, R., J. Kartenbeck, M. Büchler, J. Jedlitschky, I. Leier, and D. Keppler. 1995. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. J. Cell Biol. 131:137-150.